Director · REGENERON PHARMACEUTICALS, INC. · Common Stock
Side
SELL
Value
$486K
Shares
500
Price
$971.06
Executed
Nov 3, 2026
Disclosed
Nov 5, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 3 executedNov 5, 2026 disclosed
REGN · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+15 / 15
4 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Zoghbi Huda Y filed this Form 4 reporting a open-market sale of REGN on Nov 3, 2026. It became public on Nov 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Zoghbi Huda Ycik:0001681643
Issuer
REGENERON PHARMACEUTICALS, INC.cik:0000872589
Revision history · 0
No field has changed since this record was first ingested.
